Literature DB >> 18785272

Heterogeneity of endoscopy negative heartburn: epidemiology and natural history.

Fabio Pace, Valentina Casini, Stefano Pallotta.   

Abstract

It has now become clear that only about 40% or less of patients with heartburn and/or regurgitation have esophagitis, and that the majority of them lack visible distal esophageal mucosa breaks. These subjects are referred to as non-erosive gastroesophageal reflux disease (NERD) patients. It has been estimated that in the Western world at least one tenth of the general population has at least weekly heartburn. This proportion seems to be lower in Asia, while prevalence is rapidly increasing. Although it would be extremely useful to have prospective information regarding the fate of such patients, the natural history of NERD is largely unknown, and very few studies in the literature have addressed this issue. These studies are for the greater part old, not well conducted, and suffer from methodological drawbacks including ill-defined entry criteria. However, a review of these studies indicates that a consistent minority of NERD patients may develop erosive disease at an approximate rate of about 10% per year.

Entities:  

Mesh:

Year:  2008        PMID: 18785272      PMCID: PMC2744050          DOI: 10.3748/wjg.14.5233

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  19 in total

Review 1.  Epidemiology of gastro-oesophageal reflux disease: a systematic review.

Authors:  J Dent; H B El-Serag; M-A Wallander; S Johansson
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

2.  Will symptomatic gastroesophageal reflux disease develop into reflux esophagitis?

Authors:  Masahiro Kawanishi
Journal:  J Gastroenterol       Date:  2006-05       Impact factor: 7.527

3.  Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group.

Authors:  R Carlsson; J Dent; R Watts; S Riley; R Sheikh; J Hatlebakk; K Haug; G de Groot; A van Oudvorst; A Dalväg; O Junghard; I Wiklund
Journal:  Eur J Gastroenterol Hepatol       Date:  1998-02       Impact factor: 2.566

Review 4.  Systematic review: does gastro-oesophageal reflux disease progress?

Authors:  M Fullard; J Y Kang; P Neild; A Poullis; J D Maxwell
Journal:  Aliment Pharmacol Ther       Date:  2006-07-01       Impact factor: 8.171

5.  High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report.

Authors:  Jukka Ronkainen; Pertti Aro; Tom Storskrubb; Sven-Erik Johansson; Tore Lind; Elisabeth Bolling-Sternevald; Hans Graffner; Michael Vieth; Manfred Stolte; Lars Engstrand; Nicholas J Talley; Lars Agréus
Journal:  Scand J Gastroenterol       Date:  2005-03       Impact factor: 2.423

6.  The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus.

Authors:  Nimish Vakil; Sander V van Zanten; Peter Kahrilas; John Dent; Roger Jones
Journal:  Am J Gastroenterol       Date:  2006-08       Impact factor: 10.864

7.  Natural course of gastroesophageal reflux disease: 17-22 year follow-up of 60 patients.

Authors:  J Isolauri; M Luostarinen; E Isolauri; P Reinikainen; M Viljakka; O Keyriläinen
Journal:  Am J Gastroenterol       Date:  1997-01       Impact factor: 10.864

Review 8.  Functional esophageal disorders.

Authors:  Jean Paul Galmiche; Ray E Clouse; András Bálint; Ian J Cook; Peter J Kahrilas; William G Paterson; Andre J P M Smout
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

9.  Three- to 4.5-year prospective study of prognostic indicators in gastro-oesophageal reflux disease.

Authors:  N I McDougall; B T Johnston; J S Collins; R J McFarland; A H Love
Journal:  Scand J Gastroenterol       Date:  1998-10       Impact factor: 2.423

10.  Three year follow up of patients with gastrooesophageal reflux disease.

Authors:  N E Schindlbeck; A G Klauser; G Berghammer; W Londong; S A Müller-Lissner
Journal:  Gut       Date:  1992-08       Impact factor: 23.059

View more
  2 in total

Review 1.  Proton pump inhibitor for non-erosive reflux disease: a meta-analysis.

Authors:  Ji-Xiang Zhang; Meng-Yao Ji; Jia Song; Hong-Bo Lei; Shi Qiu; Jing Wang; Ming-Hua Ai; Jun Wang; Xiao-Guang Lv; Zi-Rong Yang; Wei-Guo Dong
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

2.  Background factors of reflux esophagitis and non-erosive reflux disease: a cross-sectional study of 10,837 subjects in Japan.

Authors:  Chihiro Minatsuki; Nobutake Yamamichi; Takeshi Shimamoto; Hikaru Kakimoto; Yu Takahashi; Mitsuhiro Fujishiro; Yoshiki Sakaguchi; Chiemi Nakayama; Maki Konno-Shimizu; Rie Matsuda; Satoshi Mochizuki; Itsuko Asada-Hirayama; Yosuke Tsuji; Shinya Kodashima; Satoshi Ono; Keiko Niimi; Toru Mitsushima; Kazuhiko Koike
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.